American International Group’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-23,528
| Closed | -$180K | – | 1317 |
|
|
2024
Q1 | $180K | Sell |
23,528
-202
| -0.9% | -$1.55K | ﹤0.01% | 2214 |
|
|
2023
Q4 | $101K | Buy |
23,730
+6,838
| +40% | +$29.1K | ﹤0.01% | 2561 |
|
|
2023
Q3 | $70.9K | Buy |
16,892
+600
| +4% | +$2.52K | ﹤0.01% | 2700 |
|
|
2023
Q2 | $90.7K | Buy |
+16,292
| New | +$90.7K | ﹤0.01% | 2650 |
|
|
2022
Q2 | – | Sell |
-7,144
| Closed | -$29K | – | 3182 |
|
|
2022
Q1 | $29K | Sell |
7,144
-503
| -7% | -$2.04K | ﹤0.01% | 2981 |
|
|
2021
Q4 | $52K | Sell |
7,647
-228
| -3% | -$1.55K | ﹤0.01% | 2944 |
|
|
2021
Q3 | $91K | Sell |
7,875
-187
| -2% | -$2.16K | ﹤0.01% | 2839 |
|
|
2021
Q2 | $137 | Buy |
8,062
+1,051
| +15% | +$18 | ﹤0.01% | 2741 |
|
|
2021
Q1 | $139 | Buy |
7,011
+2,287
| +48% | +$45 | ﹤0.01% | 2550 |
|
|
2020
Q4 | $98 | Sell |
4,724
-136
| -3% | -$3 | ﹤0.01% | 2671 |
|
|
2020
Q3 | $128K | Buy |
+4,860
| New | +$128K | ﹤0.01% | 2394 |
|